Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-27 @ 5:46 AM
Study NCT ID:
NCT04306692
Status:
TERMINATED
Last Update Posted:
2022-12-21
First Post:
2020-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Myo-inositol Versus Clomiphene Citrate in PCOS
Sponsor:
University Hospital, Ghent
Organization:
Study Overview
Official Title:
Myo-inositol Versus Clomiphene Citrate as First Line Treatment for Ovulation Induction in PCOS
Status:
TERMINATED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
clomiphene citrate is no longer being considered as standard treatment for polycystic ovary syndrome
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Specific aim: To compare inositol and the golden standard first line treatment of ovulation induction, namely clomiphene citrate.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: